UPDATE: Goldman Sachs Downgrades Acceleron Pharma (XLRN) to Sell
Tweet Send to a Friend
(Updated - April 6, 2020 4:49 AM EDT)
(updating comment)Goldman Sachs analyst Paul Choi downgraded Acceleron Pharma (NASDAQ: XLRN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Goldman Sachs analyst Paul Choi downgraded Acceleron Pharma (NASDAQ: XLRN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
